Procedure-specific subgroup findings should not be flattened into one recovery claim.
The review compared remimazolam with propofol across procedural sedation and general anesthesia. It reported similar overall success and lower hypotension and injection pain. Longer awakening and lower hypoxemia risk appeared in the procedural-sedation subgroup; those effects were not observed in the general-anesthesia subgroup.
The paper reports inconsistent participant totals in different sections, so a single overall enrollment number should not be treated as settled here. Subgroup differences also do not by themselves prove that procedure type caused the difference. Dosing and recovery definitions require attention.
When assessing recovery, identify the actual endpoint: awakening, discharge, or another milestone. The supplied review does not support describing remimazolam as uniformly faster than propofol. Its pattern instead shows why the procedural setting and endpoint definition must accompany the comparison.
Source: Publication PMC12430734, read from the supplied PDF. Applications to expert analysis are interpretation.
Related reading: Four-Trial Sedation Meta-Analysis Measures Blood Pressure More Clearly Than Recovery.